Bis-sulfonomides hydroxamic acids as matrix metalloproteinase (MMP) inhibitors
The present invention provides a compound of formula I I or pharmaceutically acceptable salts thereof wherein R1 and R2 are the same or different and are C1-10 alkyl, phenyl, hetero-aryl, or phenyl substituted with C1-4 alkyl, OR3, NHR3, CONHR3, NHCOR3, or halo; wherein R3 is H, or C1-4 alkyl; and n...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention provides a compound of formula I I or pharmaceutically acceptable salts thereof wherein R1 and R2 are the same or different and are C1-10 alkyl, phenyl, hetero-aryl, or phenyl substituted with C1-4 alkyl, OR3, NHR3, CONHR3, NHCOR3, or halo; wherein R3 is H, or C1-4 alkyl; and n is 1, 2, 3, 4, 5, or 6. The compounds are inhibitors of matrix metalloproteinases involved in tissue degradation. |
---|